Position in AMGN
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$2,430,549
+$1,081,908 QoQ
Shares Held
6,712
+75.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#1,168
of 3,140 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HARMONY ASSET MANAGEMENT LLC holds $23,235,360 across 7 Drug Manufacturers - General names. AMGN ranks #3 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,641 | $11,563,705 | |
| 2 | ABBV |
AbbVie Inc.
|
22,863 | $5,753,245 | |
| 3 | AMGN |
Amgen Inc
This page
|
6,712 | $2,430,549 | |
| 4 | JNJ |
Johnson & Johnson
|
8,341 | $2,118,363 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
4,524 | $571,562 | |
| 6 | MRK |
Merck & Co., Inc.
|
3,252 | $417,882 | |
| 7 | PFE |
Pfizer Inc
|
15,783 | $380,054 |
All Filings in AMGN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,430,549 | 6,712 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,348,641 | 3,833 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,254,579 | 3,833 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,054,581 | 3,737 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,043,407 | 3,737 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,036,526 | 3,327 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $880,181 | 3,377 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $1,088,103 | 3,377 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,055,143 | 3,377 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $959,864 | 3,376 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,343,330 | 8,136 | Shares | Sole | 2024-02-08 | |
| No filing history on record for this holder in this stock. | ||||||